| 2022-03-21 | Sale | Enanta Pharmaceuticals, Inc. ENTA | 2,676 0.0131% | $66.70 | $178,489 | -25.35% | ||
| 2019-03-11 | Sale | Enanta Pharmaceuticals, Inc. ENTA | director | 1,546 0.0077% | $99.16 | $153,301 | -31.53% | |
| 2019-02-12 | Sale | Enanta Pharmaceuticals, Inc. ENTA | director | 10,000 0.0509% | $90.00 | $900,000 | -20.45% | |
| 2019-02-11 | Sale | Enanta Pharmaceuticals, Inc. ENTA | director | 5,468 0.0176% | $56.71 | $310,077 | -19.84% | |
| 2017-06-14 | Sale | Xencor, Inc. XNCR | director | 40,000 0.0849% | $20.61 | $824,475 | +9.87% | |
| 2017-06-02 | Sale | Xencor, Inc. XNCR | director | 4,732 0.0102% | $22.00 | $104,104 | +3.52% | |
| 2017-05-26 | Sale | Xencor, Inc. XNCR | director | 24,800 0.0556% | $22.19 | $550,425 | +6.62% | |
| 2016-08-15 | Sale | Xencor, Inc. XNCR | director | 6,800 0.0163% | $22.67 | $154,148 | +1.33% | |
| 2015-06-15 | Sale | Xencor, Inc. XNCR | director | 20,000 0.0467% | $19.21 | $384,228 | -32.19% | |
| 2015-04-13 | Sale | Regulus Therapeutics Inc. RGLS | director | 20,000 0.0393% | $17.66 | $353,164 | -52.19% |